BioLife Solutions

BioLife Solutions Market capitalization

The The market capitalization of BioLife Solutions (BLFS) as of Oct 20, 2026 is 943.30 M USD. In the previous year, The market capitalization was 943.30 M USD — a change of 0.00% (lower).

Market capitalization

943.30 MUSD

YoY

0.00%

Last updated:

In 2025, BioLife Solutions's market cap stood at 943.30 M USD, a 0.00% increase from the 943.30 M USD market cap in the previous year.

The BioLife Solutions Market capitalization history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Market capitalization
Date
Market capitalization
Jan 1, 2018
943.30 M USD
Jan 1, 2019
943.30 M USD
Jan 1, 2020
943.30 M USD
Jan 1, 2021
943.30 M USD
Jan 1, 2022
943.30 M USD
Jan 1, 2023
943.30 M USD
Jan 1, 2024
943.30 M USD
Jan 1, 2025
943.30 M USD
The BioLife Solutions Market capitalization history
YEARMarket capitalizationYoY
943.30 MUSD0.00%
943.30 MUSD0.00%
943.30 MUSD0.00%
943.30 MUSD0.00%
943.30 MUSD0.00%
943.30 MUSD0.00%
943.30 MUSD0.00%
943.30 MUSD0.00%
943.30 MUSD0.00%
943.30 MUSD0.00%
943.30 MUSD0.00%
943.30 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

BioLife Solutions Stock analysis

What does BioLife Solutions do? BioLife Solutions Inc. was founded in 1998 and has since been continuously working on the development and production of bioproducts. The company is based in Bothell, Washington and employs over 50 staff members. BioLife Solutions specializes in the development of biological storage and transportation solutions, offering innovative products and services to companies in the biotechnology, cell therapy, and regenerative medicine sectors. The business model of BioLife Solutions is based on the sale of cryopreservation media and devices for packaging and storing biological materials. The company offers a wide range of products and services, including bioproducts, cryopreservation media, cell transport containers, and automatic freezers. These products allow companies in the biotechnology, cell therapy, and regenerative medicine industries to safely and effectively transport and store their products, contributing to increased product quality. BioLife Solutions works with leading biotechnology companies, cell therapy centers, and scientific institutions. The company has a strong network in the industry and is able to offer customized solutions to meet specific customer requirements. BioLife Solutions prides itself on not only providing biological products and devices to its customers but also offering expert advice and support in product selection and service. BioLife Solutions offers various divisions, such as cryopreservation media, cell transport containers, and automatic freezers. The cryopreservation media are typically mixed with cells before being frozen and stored. The special media ensure that the cells maintain their biological properties during storage and can be reactivated when needed. BioLife Solutions' cell transport containers are designed to safely transport cells without damage. These containers are available in different sizes and shapes and ensure the safe transport of cells and tissues worldwide. BioLife Solutions' automatic freezers are equipped with an intelligent system that automates the storage and management of biological materials. The products are designed to meet specific customer requirements and contribute to increased product quality. In terms of products, BioLife Solutions offers a wide range of innovative solutions. One of its most well-known products is CryoStor, a cryopreservation media frequently used in cell storage and transport. CryoStor allows companies to store and transport their cells safely and effectively. BioLife Solutions has also developed an automatic cell storage device called SmartStore, which is capable of automatically storing and monitoring biological materials. SmartStore provides an intelligent and user-friendly solution for the automatic storage of biological materials and contributes to improved product quality. BioLife Solutions' mission is to offer innovative biological products and solutions that contribute to improved product quality and simplified biological research and therapy. The company continues to strive for the development of products that meet specific customer requirements and help improve the biotechnology industry. BioLife Solutions is one of the most popular companies on Eulerpool.

Market capitalization Details

Exploring BioLife Solutions's Market Capitalization

BioLife Solutions's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of BioLife Solutions's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

BioLife Solutions's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in BioLife Solutions’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about BioLife Solutions stock

The market capitalization of BioLife Solutions is 943.30 M USD in 2025.

The market capitalization of BioLife Solutions changed from 943.30 M USD to 943.30 M USD, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The market capitalization BioLife Solutions since 2006 – with annual values, charts, and detailed analysis.

Market capitalization (German: Market capitalization, English: market capitalisation or market cap) is the calculated total value of all shares of a publicly traded company. The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company. It is determined by the supply and demand for the company's shares. Thus, market capitalization is significantly influenced by expectations in the stock market regarding the future earnings power of the company and, therefore, can be subject to significant fluctuations.

Number of shares * share price = market capitalization

To evaluate The market capitalization's USD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for The market capitalization.

A 'good' USD varies by industry and company stage. On Eulerpool, you can compare The market capitalization's BioLife Solutions with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — BioLife Solutions

All Key Metrics — BioLife Solutions